BioSpace News Archive

Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced that it has re-activated study sites and recommenced patient recruitment in a Phase 2 study of NYX-2925 in patients with fibromyalgia.

Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) today announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,772,907 (the ‘907 Patent) and allowed U.S. Patent Application No. 16/557,597 (the ‘597 Application), both entitled “Immune Modulation with TLR9 Agonists for Cancer Treatment” and each of which includes the Company’s investigational therapy tilsotolimod.

The Preeclampsia Foundation is urgently calling for the development of biomarker tests for simple, rapid, and accurate diagnosis and prediction of preeclampsia, a life-threatening hypertensive disorder of pregnancy.

Hyprevention has raised new financing to support the V-STRUT© Vertebral Implant product. The financing will be used to execute the commercialization plans for the US spinal fracture market

Abbott (NYSE: ABT), the worldwide leader in continuous glucose monitoring (CGM) technology,8 announced today it has secured CE Mark (Conformité Européenne) for its next-generation FreeStyle Libre 3 system, which is now approved for use by people living with diabetes in Europe.

Vitacore Industries Inc. has become the first Canadian company to receive Health Canada authorization to produce N95 equivalent respirators on home soil.

Sojournix, a clinical-stage biopharmaceutical company developing transformative medicines for women’s health and neuroendocrine disorders, announced today a poster presentation of data showing SJX-653 exhibits a potent NK3 antagonist profile across in vitro studies, in vivo models, and initial clinical studies in men and postmenopausal women.

Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, announced the introduction of two new products designed to enhance patient care in endoscopy and surgical imaging by improving procedural workflow: the OEP-6 high-definition printer and the WM-NP3 workstation.

A landmark study published in the American Association of Cancer Research’s (AACR) prestigious journal ‘Cancer Prevention Research’ has shown that it is possible to identify healthy individuals with higher risk of cancer based on a simple blood draw.

From the Science of Beer to learning about the benefits of GMOs; Saskatchewan is celebrating science with exciting online events and activities that showcase the province’s bioscience sector.